Author information from the last article
E-post: trygve.holmoy@medisin.uio.no
Trygve Holmøy er spesialist i nevrologi, overlege ved MS-seksjonen ved Nevrologisk avdeling, Akershus universitetssykehus og professor ved Universitetet i Oslo.
Articles by Trygve Holmøy
Disease-modifying therapy for multiple sclerosis
- Trygve Holmøy,
- Gro Owren Nygaard,
- Kjell-Morten Myhr,
- Lars Bø
10.05.2021:
High-efficacy therapy from the time of diagnosis substantially improves the prognosis for multiple sclerosis. The national guidelines on MS nevertheless recommend less effective therapy for many patients, and must be updated in pace with medical advances. We consider in the following how multiple...
The first Norwegian doctorate in multiple sclerosis
- Trygve Holmøy,
- Øystein Kalsnes Jørstad
22.03.2021:
The story of research on multiple sclerosis in Norway starts in 1945 at a private Catholic hospital in the town of Hamar, where the ophthalmologist Marius Haarr was treating patients with retinal periphlebitis and neurological symptoms. He completed his doctoral degree while raising two young...
Treatment of multiple sclerosis under the COVID-19 pandemic
- Trygve Holmøy,
- Øivind Torkildsen,
- Lars Bø
29.04.2020:
Patients with multiple sclerosis are often treated with immunosuppressants and frequently have comorbidities or functional decline. They may therefore be at increased risk of a serious course of COVID-19 if they are infected by the SARS-CoV-2 virus. The Norwegian Multiple Sclerosis Competence Centre...
A young woman with seizures, visual impairment, and paralysis
- Rune A. Høglund,
- Aija Z. Myro,
- Svetozar Zarnovicky,
- Trygve Holmøy
19.08.2019:
A young woman arrived at hospital after a new-onset seizure. Over the following months, she was hospitalised multiple times with serious neurological deficits, which turned out to be due to a relatively newly described neurological disorder. A previously healthy woman in her early twenties arrived...
Genetic testing in amyotrophic lateral sclerosis
- Ola Nakken,
- Lillian Sørum,
- Trygve Holmøy
03.09.2018:
About 150 persons develop amyotrophic lateral sclerosis (ALS) each year in Norway and this number is increasing (1). Traditionally, the condition has been regarded as a purely motor disorder characterised by progressive paralysis, but up to half of patients also develop signs of cognitive failure...
Family planning, pregnancy and breastfeeding in multiple sclerosis
- Trygve Holmøy,
- Øivind Torkildsen
08.11.2016:
Multiple sclerosis often affects women of childbearing age. The availability of more effective immunomodulatory therapy may increase the number of afflicted women wanting to fulfil their desire to have children. The purpose of this article is to provide an up-to-date review of medical issues and...
Impact of the environment on multiple sclerosis
- Kristin Ingeleiv Løken-Amsrud,
- Andreas Lossius,
- Øivind Torkildsen,
- Trygve Holmøy
19.05.2015:
The prevalence of multiple sclerosis is increasing and it is estimated that about 10 000 people in Norway have the disease (1). Multiple sclerosis reduces the lifespan by 5 – 10 years and is a frequent cause of neurological disability. Despite improved treatment, there is therefore still a need for...
Shared decision-making in decisions on treatment
- Pål Gulbrandsen,
- Eirik Hugaas Ofstad,
- Trygve Holmøy,
- Per Olav Vandvik
16.09.2014:
Legislation entitles patients to be involved in decisions on treatment that apply to themselves (shared decision-making). This sounds reasonable, and few will question this principle today. In reality, this is a complex and time-consuming process that requires guided training, in part because...